NASDAQ

Dianthus Therapeutics, Inc. (DNTH)

♥ 712 Thanks from members

Live price chart, market sentiment, and community perspectives for Dianthus Therapeutics, Inc. (NASDAQ: DNTH).

Member Opinions and Insights

Special Briefing

How to Live for 300 Years: The Longevity Sandbox

Explore plasma cleansing, somatic organ swaps, and BCI.

Explore →
Entity and Market Metadata
Sector: HealthcareIndustry: BiotechnologyFounder: Dianthus Scientific TeamLeadership: Marino Garcia (CEO)Holder: Avidity PartnersHolder: Fairmount FundsHolder: Bain Capital Life SciencesDNTH103Complement Inhibitors#DNTH#Dianthus Therapeutics#Biotech#Autoimmune Diseases#NASDAQ DNTH